Steve Cohen stock trades
Steve Cohen is a Democratic Representative for Tennessee. The 14 periodic transaction reports filed under the STOCK Act that Celsmar has read, up to 1 September 2026, disclose 22 transactions: 12 purchases and 10 sales. The tickers that appear most often are GS (2), EBS (1), FLR (1), HST (1), MS (1).
In figures
| Item | Value |
|---|---|
| Reports read | 14 |
| Transactions disclosed | 22 |
| Purchases | 12 |
| Sales | 10 |
| First report read | 10 January 2025 |
| Latest report read | 1 September 2026 |
| Most frequent tickers | GS (2), EBS (1), FLR (1), HST (1), MS (1) |
Transactions
| Trade date | Asset | Ticker | Owner | Type | Amount | Filed | Report |
|---|---|---|---|---|---|---|---|
| 21 Aug 2026 | US Treas Bills Int Rate 0.000% MAT 2/18/2027 | — | Self | Purchase | $250,001 to $500,000 | 1 Sep 2026 | Report |
| 21 Aug 2026 | US Treas Bills Int Rate 0.000% MAT 8/5/2027 | — | Self | Purchase | $250,001 to $500,000 | 1 Sep 2026 | Report |
| 6 Aug 2026 | U.S. Tres Bill Int. Rate 0.00% Mat 8/5/2027 | — | Self | Purchase | $100,001 to $250,000 | 17 Aug 2026 | Report |
| 5 Aug 2026 | JPMorgan Chase BK N A INSTL CTF DEP ACT/365 4.200% MAT 8/11/2027 | — | Self | Purchase | $100,001 to $250,000 | 17 Aug 2026 | Report |
| 27 May 2026 | US Treas Bills MAT 11/19/26 | — | Self | Purchase | $500,001 to $1,000,000 | 17 Jun 2026 | Report |
| 4 May 2026 | US Treas Bill Mat 10/29/2026 DTD 10/30/2025 | — | Self | Purchase | $50,001 to $100,000 | 20 May 2026 | Report |
| 16 Mar 2026 | METROPOLITAN GOVT NA DAVIDSON CNTY TENN HEALTH & ED L FACS BRD 3.750% 03/15/28 B | — | Self | Sale | $1,001 to $15,000 | 28 Apr 2026 | Report |
| 23 Feb 2026 | US Treasury Bills, due 8/20/2026 | — | Self | Purchase | $500,001 to $1,000,000 | 26 Mar 2026 | Report |
| 20 Feb 2026 | United States Treasury Bill Mat 5/21/26 | — | Self | Purchase | $250,001 to $500,000 | 5 Mar 2026 | Report |
| 29 Dec 2025 | Fluor Corporation Common Stock (FLR) | FLR | Self | Sale | $15,001 to $50,000 | 26 Jan 2026 | Report |
| 29 Dec 2025 | Northrop Grumman Corporation Common Stock (NOC) | NOC | Self | Sale | $15,001 to $50,000 | 26 Jan 2026 | Report |
| 17 Dec 2025 | Bank OZK - 4.625% Series A Non- Cumulative Perpetual Preferred Stock (OZKAP) | OZKAP | Self | Sale | $15,001 to $50,000 | 14 Jan 2026 | Report |
| 17 Dec 2025 | Cohen & Steers Total Return Realty Fund, Inc. Common Stock (RFI) | RFI | Self | Sale | $1,001 to $15,000 | 14 Jan 2026 | Report |
| 17 Dec 2025 | Goldman Sachs Group, Inc. (GS) | GS | Self | Sale | $15,001 to $50,000 | 14 Jan 2026 | Report |
| 17 Dec 2025 | Goldman Sachs Group, Inc. (GS) | GS | Self | Sale | $15,001 to $50,000 | 14 Jan 2026 | Report |
| 17 Dec 2025 | Morgan Stanley Common Stock (MS) | MS | Self | Sale | $50,001 to $100,000 | 14 Jan 2026 | Report |
| 18 Nov 2025 | US Treas Bill Mat 5/14/2026 | — | Self | Purchase | $250,001 to $500,000 | 16 Dec 2025 | Report |
| 21 Aug 2025 | US Treas Bill Maturity 2/19/2026 | — | Self | Purchase | $1,000,001 to $5,000,000 | 12 Sep 2025 | Report |
| 19 May 2025 | United States Treas Bills Maturity 11/13/2025 | — | Self | Purchase | $250,001 to $500,000 | 28 May 2025 | Report |
| 24 Feb 2025 | United States Treas Bills Maturity 8/21/2025 | — | Self | Purchase | $500,001 to $1,000,000 | 1 Apr 2025 | Report |
| 11 Dec 2024 | Emergent BioSolutions Inc. Common Stock (EBS) | EBS | Self | Sale | $1,001 to $15,000 | 10 Jan 2025 | Report |
| 11 Dec 2024 | Host Hotels & Resorts, Inc. - Common Stock (HST) | HST | Self | Sale | $15,001 to $50,000 | 10 Jan 2025 | Report |
Amounts are the ranges the law asks for: the reports do not give exact figures. The owner is the member, the spouse, both jointly or a dependent child.
Where each row comes from
From the periodic transaction reports that members of Congress must file within 45 days of a transaction, published by the Clerk of the House of Representatives. Each row links to the report it was read from. Celsmar keeps a copy of every document with its checksum and publishes only the reports it could read in full: 2 more reports from Steve Cohen are awaiting review and not counted here. The method is in data sources and corrected errors, in corrections.
Information prepared from the public disclosures filed with the US House of Representatives and the US Senate, for information purposes only. It is not financial advice or a recommendation to buy or sell. A disclosed transaction is not evidence of any wrongdoing. Updated on 12 November 2026.